The SFEE Code of Practice, hereinafter called “the Code”, covers the promotion of prescription only medicinal products. The “promotion” includes any activity, undertaken, organized or carried on by a pharmaceutical company or commissioned thereby, promoting the prescription, supplying, sale, administration or consumption of the medicinal product(s) of a SFEE member company. The term “medicinal products”, as used in the Code bears the meaning determined in article 1a of the of the Ministerial Decision ∆ΥΓ3α/οικ.82161 (Government Gazette 2374/Β/24.8.2012), which integrated in the Greek legal order the EU Directive 2001/83/ΕΚ, as amended by Directive 2010/84/EU.
The Code consists of two chapters and three annexes. Chapter A refers to the substantial regulations of the Code, while Chapter B refers to the Procedure for the Control of Implementation of the Code. The Annex I refers to the indicative calculation of the fee of healthcare professionals for services provided to pharmaceutical companies, Annex II refers to the Registry for non interventional clinical trials and annex III refers to the EFPIA Guidelines for the drawing up of web-pages addressed to healthcare professionals of the Associations’ members.